Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2013-000556-17Phase 4Active
Phase 4, randomised, open-label trial of levobupivacaine and morphine hydrochloride in postoperative pain (3 arms), sponsored by Fundació Parc Taulí. Primary endpoint: Pain control in the first 48 hours postoperatively. Started Apr 2013; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2013-000556-17.